Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Epistaxis, Nasopharyngitis, Rhinorrhoea
Clinical narrative: A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose; A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose; A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose; A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose), EPISTAXIS (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose), COUGH (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose) and RHINORRHOEA (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), ATORVASTATIN, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), AMLODIPINE, QUINAPRIL, SERTRALINE and ALPRAZOLAM for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose), EPISTAXIS (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose), COUGH (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose) and RHINORRHOEA (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose). The patient was treated with GUAIFENESIN (MUCINEX) for Adverse event, at a dose of 1 dosage form. At the time of the report, NASOPHARYNGITIS (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose), EPISTAXIS (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose), COUGH (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose) and RHINORRHOEA (A cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose) had not resolved.            No medical history was provided by the reporter The patient experienced a cold 10 days after receiving the booster dose and developed nosebleeds along with cough and runny nose. Patient stated symptoms are ongoing, the cold has continued on for more than 6 weeks.